HEP B-host junction test: a blood test for early detection of primary and recurrent hepatitis B-related hepatocellular carcinoma

Active Project Grant Awarded

Award ID
HT9425261E116
Recipient
Awarding agency
Obligated
$3,499,290

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 14% complete
Place of performance
Boston, MA 02114, USA

Award details come from USAspending.gov.

About this award

The Defense Health Agency awarded The General Hospital Corporation, doing business as Massachusetts General Hospital, $3.49929 million on April 24, 2026, as a Project Grant under Assistance Listing 12.420, Military Medical Research and Development. The award funds the HEP B-HOST Junction Test, a blood test for early detection of primary and recurrent hepatitis B-related hepatocellular carcinoma. The period of performance ends June 30, 2030, and the place of performance is Boston, Massachusetts 02114.

The recipient sub-awarded work to Baruch S. Blumberg Institute on June 30, 2026, under award HT9425261E116-GR1005272-S01. The Blumberg team pursues three aims. The first refines and analytically validates a blood-based HBV-JS test using spike-in controls and matched tumor-plasma samples, and establishes analytical performance of the HBV-NGS assay for liquid biopsy use. The second develops and validates the HBV-JS liquid biopsy as a surveillance test for early detection of HBV-related hepatocellular carcinoma, using archived plasma from 150 HBV-HCC patients, 100 with HBV cirrhosis, and 100 with HBV hepatitis, split into an open-labeled training set and a blinded validation set. The third develops and validates the test for detecting post-operative recurrence, using serial plasma from 150 patients undergoing curative resection, 50 of whom have MRI-confirmed recurrence.

Subawards

Subrecipient Amount Awarded
Baruch S. Blumberg Institute Dr. Su and her team at Blumberg will work towards these three aims: Specific Aim 1: Refine and analytically validate a blood-based HBV-JS test using spike-in… $391,500

Quick answers

Who received award HT9425261E116?

HT9425261E116 was awarded to The General Hospital Corporation by Defense Health Agency (Department of Defense) on April 24, 2026.

How much is award HT9425261E116 worth?

$3,499,290 has been obligated on HT9425261E116.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award